Bone‐Targeted Delivery of Cell‐Penetrating‐RUNX2 Fusion Protein in Osteoporosis Model
Advanced Science · 2023
DOI: 10.1002/advs.202301570 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Seoyeon Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical and Biological Engineering, Institute of Chemical Processes, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Repu…. Hauptthemen laut MEDLINE: Osteoporosis, Core Binding Factor Alpha 1 Subunit, Drug Delivery Systems, Cell-Penetrating Peptides. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
The onset of osteoporosis leads to a gradual decrease in bone density due to an imbalance between bone formation and resorption. To achieve optimal drug efficacy with minimal side effects, targeted drug delivery to the bone is necessary. Previous studies have utilized peptides that bind to hydroxyapatite, a mineral component of bone, for bone‐targeted drug delivery. In this study, a hydroxyapatite binding (HAB) tag is fused to 30Kc19α‐Runt‐related transcription factor 2 (RUNX2) for bone‐targeting. This recombinant protein can penetrate the nucleus of human mesenchymal stem cells (hMSCs) and act as a master transcription factor for osteogenesis. The HAB tag increases the binding affinity of 30Kc19α‐RUNX2 to mineral deposition in mature osteoblasts and bone tissue, without affecting its osteogenic induction capability. In the osteoporosis mouse model, intravenous injection of HAB‐30Kc19α‐RUNX2 results in preferential accumulation in the femur and promotes bone formation while reducing toxicity in the spleen. These findings suggest that HAB‐30Kc19α‐RUNX2 may be a promising candidate for bone‐targeted therapy in osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical and Biological Engineering, Institute of Chemical Processes, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea.
- Interdisciplinary Program in Bioengineering, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea.
- BioMAX/N-Bio Institute, Institute of BioEngineerig, Seoul National University, 1 Gwanakro, Gwanak-gu, Seoul, 08826, Republic of Korea.
- Department of Nutritional Science and Food Management, Ewha Womans University, 52, Ewhayeodae-gil, Seodaemun-gu, Seoul, 03760, Republic of Korea.
ORCID-Profile: Seoyeon Kim, Tai Hyun Park, Nathaniel S Hwang
Förderung
- Ministry of Science and ICT, South Korea
Zitieren
APA
Kim, S., Lee, H., Hong, J., Kim, S. H. L., Kwon, E., Park, T. H., & Hwang, N. S. (2023). Bone‐Targeted Delivery of Cell‐Penetrating‐RUNX2 Fusion Protein in Osteoporosis Model. Advanced Science. https://doi.org/10.1002/advs.202301570
Vancouver
Kim S, Lee H, Hong J, Kim SHL, Kwon E, Park TH, et al. Bone‐Targeted Delivery of Cell‐Penetrating‐RUNX2 Fusion Protein in Osteoporosis Model. Advanced Science. 2023. doi:10.1002/advs.202301570
BibTeX
@article{Kim2023,
author = {Kim, Seoyeon and Lee, Haein and Hong, Jiyeon and Kim, Seung Hyun L and Kwon, Euntaek and Park, Tai Hyun and Hwang, Nathaniel S},
title = {Bone‐Targeted Delivery of Cell‐Penetrating‐RUNX2 Fusion Protein in Osteoporosis Model},
journal = {Advanced Science},
year = {2023},
doi = {10.1002/advs.202301570}
}
EUVIMED